Cargando…

Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis

Portal hypertension is a direct consequence of hepatic fibrosis, and several hepatic fibrosis markers have been evaluated as a noninvasive alternative to the detection of portal hypertension and esophageal varices. In the present study, we compared the diagnostic and prognostic values of the noninva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Eun Ju, Kim, Moon Young, Lee, Jeong-Hoon, Lee, Il Young, Lim, Yoo Li, Choi, Dae Hee, Kim, Yoon Jun, Yoon, Jung-Hwan, Baik, Soon Koo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511411/ https://www.ncbi.nlm.nih.gov/pubmed/26196942 http://dx.doi.org/10.1371/journal.pone.0133935

Ejemplares similares

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
por: Lim, Yoo Li, et al.
Publicado: (2016)

The Accuracy of Ultrasonography for the Evaluation of Portal Hypertension in Patients with Cirrhosis: A Systematic Review
por: Kim, Gaeun, et al.
Publicado: (2015)

Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis
por: Kim, Gaeun, et al.
Publicado: (2017)

Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension
por: Shim, Kwang Yong, et al.
Publicado: (2018)

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data
por: Kim, Hyung Ki, et al.
Publicado: (2014)

Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study
por: Lim, Yoo Li, et al.
Publicado: (2017)

Accuracy of noninvasive tests in the prediction of portal hypertensive gastropathy in Egyptian patients with cirrhosis
por: Amer, Ibrahim F, et al.
Publicado: (2021)

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
por: Kim, Jae Hyun, et al.
Publicado: (2014)

Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
por: Hong, Won Ki, et al.
Publicado: (2014)

Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis
por: Gupta, Haripriya, et al.
Publicado: (2019)

Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis
por: Yu, Su Jong, et al.
Publicado: (2017)

Measuring Intrahepatic Vascular Changes Using Contrast-Enhanced Ultrasonography to Predict the Prognosis of Alcoholic Hepatitis Combined with Cirrhosis: A Prospective Pilot Study
por: Park, Min Sun, et al.
Publicado: (2018)

The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis
por: Kang, Seong Hee, et al.
Publicado: (2018)

Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis
por: Wang, Le, et al.
Publicado: (2017)

Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
por: Kim, Ji Hyun, et al.
Publicado: (2020)

Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis
por: Kim, Moon Young, et al.
Publicado: (2010)

Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model
por: Rabiee, Anahita, et al.
Publicado: (2022)

The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis
por: Ryu, Se Ri, et al.
Publicado: (2021)

Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis
por: Kim, Gaeun, et al.
Publicado: (2017)

12-O-tetradecanoylphorbol-13-acetate Reduces Activation of Hepatic Stellate Cells by Inhibiting the Hippo Pathway Transcriptional Coactivator YAP
por: Kim, Chang Wan, et al.
Publicado: (2022)

The kidney in cirrhosis with portal hypertension
por: Olteanu, D, et al.
Publicado: (2010)

Portal hypertensive gastropathy as a prognostic index in patients with liver cirrhosis
por: Bang, Chang Seok, et al.
Publicado: (2016)

Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients
por: Han, Ji Min, et al.
Publicado: (2023)

Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: A multicenter study
por: Kim, Ji Hyun, et al.
Publicado: (2022)

Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score
por: Kang, Seong Hee, et al.
Publicado: (2018)

Ultrasonography for Noninvasive Assessment of Portal Hypertension
por: Maruyama, Hitoshi, et al.
Publicado: (2017)

Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension
por: Cunningham, Morven E., et al.
Publicado: (2019)

Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease: Definition and subtypes
por: Han, Seul Ki, et al.
Publicado: (2023)

Advances and challenges in cirrhosis and portal hypertension
por: Berzigotti, Annalisa
Publicado: (2017)

Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol
por: Yoon, Jae Hyun, et al.
Publicado: (2021)

The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data
por: Hong, Won Ki, et al.
Publicado: (2013)

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Han, Seul Ki, et al.
Publicado: (2023)

Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
por: Chun, Ho Soo, et al.
Publicado: (2021)

Surveillance for portal hypertension in the course of liver cirrhosis
por: Piekarska, Anna, et al.
Publicado: (2018)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Extrapulmonary Sarcoidosis Manifested as Cirrhosis with Portal Hypertension
por: Kothakota, Sunil Raviraj, et al.
Publicado: (2021)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

A clinical predictor of varices and portal hypertensive gastropathy in patients with chronic liver disease
por: Min, Yang Won, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3hdvo7q41sf9ce79pluocclr76